CytomX Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
CTMX chart
What traders are saying about $CTMX
Latest postsCytomX Therapeutics, Inc. news
- Cytomx Therapeutics Stock Price Forecast. Should You Buy CTMX?
StockInvest.us ·
- Wedbush maintains CytomX Therapeutics at Outperform, raises price target to $12 from $11
TradingView ·
- Wedbush Raises Price Target on CytomX Therapeutics to $12 From $11, Keeps Outperform Rating
Moomoo ·
- What Does the Varseta-M Development Program Mean for CytomX Therapeutics, Inc. (NASDAQ:CTMX) in 2027?
Kalkine ·
- CytomX (CTMX) Q3 2026 Earnings Call Transcript
fool.com ·
- CytomX Therapeutics (NasdaqGS:CTMX) Stock Forecast & Analyst Predictions
Simply Wall St ·
- CytomX Therapeutics Q3 Earnings Call Highlights
marketbeat.com ·
- CytomX Therapeutics Reports Q3 2026 Financial Results: Revenue M
GuruFocus ·
- CytomX Therapeutics Q3 2026 Earnings Call Transcript
Benzinga ·
- CytomX Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- CytomX Therapeutics Inc earnings missed by $0.02, revenue fell short of estimates
Investing.com ·
- CytomX Therapeutics Q3 2026 Earnings Call Is Live
TradingView ·
CytomX Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $76.2M | $138.1M | $101.2M | $53.2M |
| Net income | -$17.4M | $31.9M | -$569,000 | -$99.3M |
| Total assets (year end) | $151.6M | $120.5M | $201.8M | $260.9M |
| Cash and equivalents (year end) | $12.7M | $38.1M | $17.2M | $193.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About CytomX Therapeutics, Inc.
- Ticker
- CTMX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1501989
Frequently asked questions
What exchange is CytomX Therapeutics, Inc. listed on?
CytomX Therapeutics, Inc. trades on the Nasdaq under the ticker symbol CTMX.
What industry is CytomX Therapeutics, Inc. in?
CytomX Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is CytomX Therapeutics, Inc. headquartered?
CytomX Therapeutics, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does CytomX Therapeutics, Inc.'s fiscal year end?
CytomX Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did CytomX Therapeutics, Inc. report?
CytomX Therapeutics, Inc. reported $76.2M in revenue for calendar year 2025, according to its SEC filings.